Biotech RadarJobs updated

COMPANY

Hikma

HQ: London, United Kingdom source · hikma.com ↗

Clinical Phase 2

147 open jobs · last seen Oct 23, 2026 · 14 sources

Keywords: oncology respiratory Relapsing-Remitting Multiple Sclerosis Acute Myeloid Leukemia Acute Myeloid Leukaemia Chronic Myeloid Leukemia Schizophrenia Chronic Myelogenous Leukemia Inflammatory Bowel Diseases Crohn Disease Fistulizing Crohn's Disease Ulcerative Colitis Non-Small-Cell Lung Carcinoma Rheumatoid Arthritis Primary Hypercholesterolemia Imatinib Azacitidine Fingolimod Dimethyl Fumarate Dasatinib Infliximab Biosimilar Infliximab Mycophenolate Mofetil Rosuvastatin

Profile checked Oct 10, 2026

147+1 patient-care hiddenOpen jobs14Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Mechanic I, FacilityBedford, Ohio, United StatesOct 23, 2026Oct 23, 2026
Chemical Process Operator I-2nd ShiftCherry Hill, New Jersey, United StatesOct 23, 2026Oct 23, 2026
Package Operator IBedford, Ohio, United StatesOct 23, 2026Oct 23, 2026
Logistics TechnicianColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026
Team Lead, Manufacturing / Production 1st/2nd/3rd ShiftsColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026

See all 147 jobs

Timeline

  1. Trial start Not phased (device or behavioral study): Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients source ↗
  2. Trial start Phase 1: Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML) source ↗
  3. Trial start —: Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid Leukemia source ↗
  4. Trial start —: Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in Egypt source ↗
  5. Trial start —: Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia source ↗
  6. Trial start —: Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA source ↗
  7. Trial start C: Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia source ↗
  8. Trial start —: Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients source ↗
  9. Trial start —: Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt source ↗
  10. Trial start Phase 4: Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients. source ↗
  11. Trial start —: Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan source ↗
  12. Trial start —: Efficacy and Safety of a Generic Rosuvastatin in a Real-world Setting source ↗
  13. Trial start —: Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan source ↗
  14. Trial start —: Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan source ↗

Clinical trials (lead sponsor) 14

RecordTitlePhaseStatusStartPrimary completion
NCT06572982Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) PatientsNot phased (device or behavioral study)Active, not recruitingApr 29, 20252026-05 (estimated)
NCT06326697Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)Phase 1CompletedMay 2, 2024Aug 17, 2025 (actual)
NCT05282108Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid LeukemiaNot listedRecruitingJul 20, 20222026-08 (estimated)
NCT05423769Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in EgyptNot listedCompletedJan 19, 2022Nov 30, 2023 (actual)
NCT04468165Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA RegionNot listedCompletedFeb 23, 2021Jul 20, 2023 (actual)
NCT05563818Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With SchizophreniaNot listedCompletedNov 9, 2021Dec 20, 2022 (actual)
NCT03625388Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaCCompletedNov 5, 2018Jul 22, 2023 (actual)
NCT03452501Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia PatientsNot listedCompletedAug 26, 2018Aug 17, 2020 (actual)
NCT03454503Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in EgyptNot listedCompletedMay 13, 2018Dec 28, 2020 (actual)
NCT03460678Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.Phase 4TerminatedFeb 28, 2018Nov 14, 2018 (actual)
NCT03348046Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in JordanNot listedCompletedMar 23, 2017Apr 14, 2019 (actual)
NCT03517982Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in JordanNot listedCompleted2014-102016-09 (actual)
NCT03516955Efficacy and Safety of a Generic Rosuvastatin in a Real-world SettingNot listedCompleted2014-112015-08 (actual)
NCT02977312Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in JordanNot listedCompleted2012-082015-02 (actual)

Open jobs 147

1 patient-care job hidden (phlebotomy, plasma-center, nursing and similar care roles; 148 open jobs in total).

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Mechanic I, FacilityBedford, Ohio, United StatesOct 23, 2026Oct 23, 2026Not stated
Chemical Process Operator I-2nd ShiftCherry Hill, New Jersey, United StatesOct 23, 2026Oct 23, 2026Not stated
Package Operator IBedford, Ohio, United StatesOct 23, 2026Oct 23, 2026Not stated
Logistics TechnicianColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Team Lead, Manufacturing / Production 1st/2nd/3rd ShiftsColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Technician, Production Reliability, Sunday-Thursday 10:45PM-7:15AM; potential temporary weekend shiColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Coordinator, Quality AssuranceSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Technician I, PackagingSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Officer, LIMSSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Specialist, Production SystemsCherry Hill, New Jersey, United StatesOct 22, 2026Oct 12, 2026Not stated
Technician I, InspectionSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Analyst, Quality AssuranceSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Analyst, Quality AssuranceSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Technician I, BulkSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Project Manager, Brand MarketingBerkeley Heights, New Jersey, United StatesOct 22, 2026Oct 12, 2026Not stated
Engineer, Operational TechnologySintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Trainee, Technical AffairsSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Team Leader, PackagingSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Technician III, MaintenanceSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Technician I, PackagingSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Analyst, Quality AssuranceSintra, PortugalOct 22, 2026Oct 14, 2026Not stated
Technician I, BagsSintra, PortugalOct 22, 2026Oct 14, 2026Not stated
Team Leader, InspectionSintra, PortugalOct 22, 2026Oct 15, 2026Not stated
Analyst, Quality ControlSintra, PortugalOct 22, 2026Oct 15, 2026Not stated
Analyst, Quality AssuranceSintra, PortugalOct 22, 2026Oct 20, 2026Not stated
Automation EngineerCherry Hill, New Jersey, United StatesOct 22, 2026Oct 22, 2026Not stated
Medical Representative - TangierCasablanca, MoroccoOct 22, 2026Oct 23, 2026Not stated
Sr. Specialist, FP&A - GroupAmman, JordanOct 22, 2026Oct 23, 2026Not stated
Electronic Instrumentation TechnicianCherry Hill, New Jersey, United StatesOct 22, 2026Oct 23, 2026Not stated
Electronic Instrumentation Technician - 3rd ShiftCherry Hill, New Jersey, United StatesOct 22, 2026Oct 23, 2026Not stated
Técnico de Produção de Líquidos (8H)Sintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Engineer, InfrastructureSintra, PortugalOct 22, 2026Oct 12, 2026Not stated
Técnico de Manutenção H2 - 8HSintra, PortugalOct 22, 2026Oct 14, 2026Not stated
Pharmaceutical Manufacturing Technician (Manufacturing/Production)Columbus, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Research & Development PharmacistGiza, EgyptOct 22, 2026Oct 12, 2026Not stated
Senior Accounts Payable AccountantGiza, EgyptOct 22, 2026Oct 12, 2026Not stated
Medical Representative - MarrakechCasablanca, MoroccoOct 22, 2026Oct 22, 2026Not stated
AccountantGiza, EgyptOct 22, 2026Oct 23, 2026Not stated
Associate Manager, Claims & ReturnsAmman, JordanOct 22, 2026Oct 23, 2026Not stated
Medical Representative - CasablancaCasablanca, MoroccoOct 22, 2026Oct 22, 2026Not stated
Medical Representative - MarrakechCasablanca, MoroccoOct 22, 2026Oct 22, 2026Not stated
Corporate Event Planning & Management SpecialistGiza, EgyptOct 22, 2026Oct 12, 2026Not stated
Quality Control Analyst (Tamheer Program)Riyadh, Saudi ArabiaOct 22, 2026Oct 12, 2026Not stated
Shipping Officer (Tamheer Program)Riyadh, Saudi ArabiaOct 22, 2026Oct 12, 2026Not stated
Generalist, PeopleColumbus, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Fill Operator I - IV Bags - 1st ShiftBedford, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Fill Operator I - Lyo - 1st ShiftBedford, Ohio, United StatesOct 22, 2026Oct 12, 2026Not stated
Quality Assurance On the FloorPavia, ItalyOct 22, 2026Oct 12, 2026Not stated
Analyst, Portfolio & Offer DevelopmentBerkeley Heights, New Jersey, United StatesOct 22, 2026Oct 12, 2026Not stated

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

All 147 jobs →

Connect

See your connections at Hikma on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-18

Feedback